🇺🇸 FDA
Company

Moleculin

Moleculin Biotech

MBRX biotech USA

Quick answer

Moleculin is a biotech company (MBRX) headquartered in HOUSTON, TX, USA with 7 tracked pipeline programs.

Pipeline (7)

project

Placebo in combination with Cytarabine Injection

Acute Myeloid Leukaemia (AML)

Phase 3 · small_molecule · active

1 trials project

Liposomal Annamycin

Leukemia, Myeloid, Acute

Phase 2 · small_molecule · completed

3 trials project

Liposomal Annamycin (L-Annamycin)

Sarcoma,Soft Tissue

Phase 2 · small_molecule · completed

1 trials project

MOL4239

Psoriasis

Phase 2 · small_molecule · completed

1 trials project

STAT3 Inhibitor WP1066

Glioblastoma, IDH-Wildtype

Phase 2 · small_molecule · active

1 trials project

WP1122

Healthy Volunteer

Phase 1 · small_molecule · completed

1 trials project

WP1220

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Phase 1 · small_molecule · completed

1 trials

Patents (1)

patent

US 8450337

Methods of treating skin disorders with caffeic acid analogs

Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)